CXCL12 and neoplasm: SRC is also downstream of the SDF1/CXCR4 signaling axis [140], which facilitates mobilization of inflammatory leukocytes and bone marrow-derived mesenchymal cells during pancreatitis and tumor development [141, 142], and enables pancreatic cancer cell invasion and EMT [143, 144].